Table 3.
Total | Disease N (%) | OR (95% CI) | AOR (95% CI) | |
---|---|---|---|---|
Child factors | ||||
Age < 2 years | 64 | 20 (31.3%) | ref | ref |
Age ≥ 2 years | 144 | 22 (15.3%) | 0.40 (0.20, 0.80) | 0.32 (0.15, 0.71) |
HIV negative | 202 | 40 (19.8%) | ref | ref |
HIV positive | 3 | 2 (66.7%) | 8.10 (0.72, 91.57) | 23.0 (1.11, 477.86) |
No BCG scar / no vaccination documented | 16 | 3 (18.8%) | ref | ref |
BCG scar / vaccination documented | 191 | 39 (20.4%) | 1.11 (0.30, 4.09) | 1.14 (0.21, 6.20) |
Weight for age (z-score) ≥ −2 | 186 | 34 (18.3%) | ref | ref |
Weight for age (z-score) < −2 | 21 | 7 (33.3%) | 2.24 (0.84, 5.96) | 2.17 (0.72, 6.55) |
Adult source case factors | ||||
DS-TB | 107 | 27 (25.2%) | ref | ref |
MDR-TB | 101 | 15 (14.9%) | 0.52 (0.26, 1.04) | 0.43 (0.19, 0.97) |
Smear-negative source case | 43 | 4 (9.3%) | ref | ref |
Smear-positive source case | 155 | 35 (22.6%) | 2.84 (0.95, 8.51) | 4.24 (1.31, 13.78) |
MDR-TB Mycobacterium tuberculosis resistant to rifampicin and isoniazid (defined by line probe assay)
DS-TB Mycobacterium tuberculosis susceptible to rifampicin and isoniazid (defined by line probe assay)